PRS
Use
Polygenic Risk Scores (PRS) aggregate the effects of thousands to millions of genetic variants across the whole genome—including intergenic and regulatory regions—to assess an individual’s predisposition to common diseases such as cardiovascular disease, diabetes, and various cancers. Reports offer providers enhanced risk stratification, enabling personalized prevention plans and early identification of high-risk individuals to improve long-term outcomes.
Special Instructions
Allelica offers more than 20 different PRSs; providers can select single PRS reports, build custom PRS panels, or deploy white-label reports. Integration into clinical workflows is seamless, with reports designed for clarity and actionable insights.
Limitations
Not provided.
Methodology
NGS
Biomarkers
Result Turnaround Time
21-56 days
Related Documents
For more information, please review the documents below
Not provided.
Other tests from different labs that may be relevant